Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Δεκέμβριος 1999News Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 Δεκέμβριος 1999Press release Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 Δεκέμβριος 1999News Committee for veterinary medicinal products: 50th meeting 9 Δεκέμβριος 1999Press releaseVeterinary Twenty-fourth Meeting of the Management Board 2 Δεκέμβριος 1999Press releaseCorporate Committee for Proprietary Medicinal Products (CPMP) 54th plenary meeting 22 Νοέμβριος 1999Press release Meeting of the EMEA working party on herbal medicinal products 28 and 29 October 1999 18 Νοέμβριος 1999NewsHerbal Committee for Veterinary Medicinal Products: 49th meeting 11 Νοέμβριος 1999Press releaseVeterinary Public Statement on Leflunomide (Arava) - Pancytopenia and Serious Skin Reactions 25 Οκτώβριος 1999News Committee for Proprietary Medicinal Products (CPMP) 53rd plenary meeting 25 Οκτώβριος 1999Press release 1 … 367 368 369 370 371 Page 371 of 384 372 373 374 375 … 384
Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Δεκέμβριος 1999News
Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 Δεκέμβριος 1999Press release
Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 Δεκέμβριος 1999News
Committee for Proprietary Medicinal Products (CPMP) 54th plenary meeting 22 Νοέμβριος 1999Press release
Meeting of the EMEA working party on herbal medicinal products 28 and 29 October 1999 18 Νοέμβριος 1999NewsHerbal
Public Statement on Leflunomide (Arava) - Pancytopenia and Serious Skin Reactions 25 Οκτώβριος 1999News
Committee for Proprietary Medicinal Products (CPMP) 53rd plenary meeting 25 Οκτώβριος 1999Press release
